scispace - formally typeset
J

Javier Godino

Researcher at University of Zaragoza

Publications -  40
Citations -  3191

Javier Godino is an academic researcher from University of Zaragoza. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 19, co-authored 39 publications receiving 3039 citations. Previous affiliations of Javier Godino include Hospital Clínico San Carlos.

Papers
More filters
Journal ArticleDOI

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.

TL;DR: Two SNPs consistently associated with breast cancer are identified: rs3803662 is near the 5′ end of TNRC9 , a high mobility group chromatin–associated protein whose expression is implicated in breast cancer metastasis to bone.
Journal ArticleDOI

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.

TL;DR: A genome-wide association study of breast cancer predisposition with replication and refinement studies involving 6,145 cases and 33,016 controls identified two SNPs on 5p12 that confer risk, preferentially for ER-positive tumors.
Journal ArticleDOI

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

Julius Gudmundsson, +72 more
- 01 Mar 2008 - 
TL;DR: The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.
Journal ArticleDOI

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

TL;DR: In a multivariate analysis using 22 prostate cancer risk variants typed in the Icelandic population, it is estimated that carriers in the top 1.3% of the risk distribution are at a 2.5 times greater risk of developing the disease than members of the general population.
Journal ArticleDOI

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Timothy R. Rebbeck, +261 more
- 07 Apr 2015 - 
TL;DR: In this paper, the relationship between specific mutations in BRCA1 and cancer risk has been investigated and limited information about the relationship has been available about specific mutations for specific mutations.